Only a New Zealand-registered doctor can assess your medical history and decide whether Wegovy® is appropriate for you. This is based on current clinical guidelines and your personal health history.

As with any medicine, Wegovy® may cause side effects. Possible side effects may include nausea, fatigue, or constipation, especially early in treatment. Your healthcare provider can help you manage any adverse effects and adjust your treatment if necessary.

Wegovy® is administered as a once-weekly injection using a pre-filled pen. Most people take it at home after receiving proper guidance from a healthcare provider. Your prescriber will explain how to use the pen safely and confidently.

Not everyone is suitable for treatment with Wegovy®. A registered healthcare provider will assess your health history and other factors to determine if this medication is appropriate for you. This process helps ensure safe and effective care.

Wegovy® is approved for adults with obesity or overweight conditions, particularly those with a body mass index (BMI) of 27 or higher. It is also suitable for individuals with weight-related health issues, such as type 2 diabetes.

If prescribed, you’ll receive support from your practitioner and access to content designed to help you stay informed throughout your treatment journey. This includes progress tracking and check-ins to review how you’re doing.

For detailed information about Wegovy®, talk to your doctor or pharmacist. You can also visit medsafe.govt.nz to access the official datasheet. Keep in mind that this site is intended for general information and doesn’t replace medical advice.

Wegovy® is a prescription medicine that contains semaglutide. It belongs to a class of medicines called GLP-1 receptor agonists, which were originally developed to help manage blood sugar levels in people with type 2 diabetes.

Wegovy® can be used alongside a reduced-calorie diet and physical activity to help lower the risk of serious heart problems such as heart attack, stroke or death, in adults with established heart disease who are also living with obesity or excess weight.

Wegovy® should only be used under the guidance of a registered healthcare professional.

Wegovy® helps reduce appetite by mimicking a natural hormone that affects the parts of the brain responsible for hunger and food intake. This can help you feel fuller for longer and eat less, supporting weight loss.

The recommended dosing of Wegovy® typically starts at a lower dose, such as 0.25 mg weekly, and may be gradually increased to 2.4 mg per week. This gradual increase helps to minimise side effects and allows the body to adjust to the medication effectively. It is crucial to follow your healthcare provider's instructions regarding Wegovy® dosing.

At Moshy, Wegovy® is available as part of our medical weight loss program available for $629 per month (approximately $21/day*), which includes ongoing clinical support, consultations, and community access. Learn more about our program

*Subject to eligibility. Your practitioner will determine if Wegovy is clinically appropriate for you.

Yes, Wegovy® is designed not only to promote weight loss but also to help individuals maintain their weight reduction. By continuing the use of Wegovy® as part of a comprehensive weight management plan, individuals can better manage their weight and reduce excess body weight over the long term.

Wegovy® is administered as a one-weekly injection using a pre-filled injection pen. It is important to follow the instructions provided by your healthcare provider for injecting Wegovy® properly. The injection may be done in various areas of the body, such as the abdomen or thigh, and it should be rotated to different injection sites to minimise discomfort.

Wegovy® may be used alongside certain other medications. However, it is crucial to consult a healthcare provider before combining Wegovy® with any other medications to ensure safety and effectiveness.